TY - JOUR
T1 - Cognitive functioning in thyroid cancer survivors
T2 - a systematic review and meta-analysis
AU - Saeed, Omar
AU - Bernstein, Lori J.
AU - Fazelzad, Rouhi
AU - Samuels, Mary
AU - Burmeister, Lynn A.
AU - Thabane, Lehana
AU - Ezzat, Shereen
AU - Goldstein, David P.
AU - Jones, Jennifer
AU - Sawka, Anna M.
N1 - Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2019/4/15
Y1 - 2019/4/15
N2 - Background: Some thyroid cancer (TC) survivors experience cognitive symptoms. Purpose: The purpose of this study is to perform a systematic literature review and meta-analysis comparing cognitive performance in TC survivors to controls. Methods: We performed a seven-database electronic search and hand-search. We performed duplicate independent reviews and data abstraction. Random effects meta-analyses reported standardized mean differences (SMDs) with 95% confidence intervals (CIs), where a negative value implies worse performance in the TC group. Results: We reviewed 1174 unique citations and 10 full-text papers. We included seven studies of 241 treated TC survivors and 273 controls. Cognitive function was statistically significantly worse in TC survivors in the following domains: Attention and Concentration (Digit Span Forwards) SMD − 0.37 (95% CI − 0.62, − 0.13, p = 0.003, four studies), Speed of Processing (Trail Making A) SMD − 0.36 (95% CI − 0.66, − 0.05, p = 0.022, four studies), and Language (Controlled Oral Word Association [COWAT]-Categories) SMD − 0.97 (95% − 1.31, − 0.64, p < 0.001, two studies). Executive Function results varied: COWAT-Letters SMD − 0.60 (95% CI − 0.94, − 0.27, p < 0.001, two studies), Digit Span Backwards SMD − 0.40 (95% CI − 0.64, − 0.15, p = 0.002, four studies), and Trail Making B test SMD − 0.20 (95% CI − 0.51, 0.10, p = 0.191, four studies). Statistical heterogeneity limited the COWAT-Categories and Digit Span Backwards meta-analyses. Conclusions: Cognitive function was worse in TC survivors in multiple domains. Limitations included few studies, potential confounding, and lack of prospective data. Implications for Cancer Survivors: TC survivors may experience impairments in cognitive function and should report cognitive concerns to healthcare practitioners.
AB - Background: Some thyroid cancer (TC) survivors experience cognitive symptoms. Purpose: The purpose of this study is to perform a systematic literature review and meta-analysis comparing cognitive performance in TC survivors to controls. Methods: We performed a seven-database electronic search and hand-search. We performed duplicate independent reviews and data abstraction. Random effects meta-analyses reported standardized mean differences (SMDs) with 95% confidence intervals (CIs), where a negative value implies worse performance in the TC group. Results: We reviewed 1174 unique citations and 10 full-text papers. We included seven studies of 241 treated TC survivors and 273 controls. Cognitive function was statistically significantly worse in TC survivors in the following domains: Attention and Concentration (Digit Span Forwards) SMD − 0.37 (95% CI − 0.62, − 0.13, p = 0.003, four studies), Speed of Processing (Trail Making A) SMD − 0.36 (95% CI − 0.66, − 0.05, p = 0.022, four studies), and Language (Controlled Oral Word Association [COWAT]-Categories) SMD − 0.97 (95% − 1.31, − 0.64, p < 0.001, two studies). Executive Function results varied: COWAT-Letters SMD − 0.60 (95% CI − 0.94, − 0.27, p < 0.001, two studies), Digit Span Backwards SMD − 0.40 (95% CI − 0.64, − 0.15, p = 0.002, four studies), and Trail Making B test SMD − 0.20 (95% CI − 0.51, 0.10, p = 0.191, four studies). Statistical heterogeneity limited the COWAT-Categories and Digit Span Backwards meta-analyses. Conclusions: Cognitive function was worse in TC survivors in multiple domains. Limitations included few studies, potential confounding, and lack of prospective data. Implications for Cancer Survivors: TC survivors may experience impairments in cognitive function and should report cognitive concerns to healthcare practitioners.
KW - Cancer survivorship
KW - Meta-analysis
KW - Neurocognitive function
KW - Systematic review
KW - Thyroid cancer
UR - http://www.scopus.com/inward/record.url?scp=85064925048&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064925048&partnerID=8YFLogxK
U2 - 10.1007/s11764-019-00745-1
DO - 10.1007/s11764-019-00745-1
M3 - Review article
C2 - 30949895
AN - SCOPUS:85064925048
SN - 1932-2259
VL - 13
SP - 231
EP - 243
JO - Journal of Cancer Survivorship
JF - Journal of Cancer Survivorship
IS - 2
ER -